{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:51Z","timestamp":1791919611276,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejca.2022.02.018","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:19:03Z","timestamp":1648156743000},"page":"254-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A\u00a0systematic review and meta-analysis"],"prefix":"10.1016","volume":"166","author":[{"given":"Tiuri E.","family":"Kroese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W.M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lordick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle P.","family":"Ruurda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D'Ugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"van Cutsem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7134-261X","authenticated-orcid":false,"given":"Richard","family":"van Hillegersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.N.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2022.02.018_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib3","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.02.018_bib4","article-title":"Phase 2 study of stereotactic body radiation therapy for patients with oligometastatic esophageal squamous cell carcinoma","author":"Liu","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ejca.2022.02.018_bib5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","article-title":"Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial","volume":"3","author":"Al-Batran","year":"2017","journal-title":"JAMA Oncol"},{"issue":"39","key":"10.1016\/j.ejca.2022.02.018_bib6","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.3748\/wjg.v26.i39.6037","article-title":"Metastatic pattern in esophageal and gastric cancer: influenced by site and histology","volume":"26","author":"Verstegen","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ejca.2022.02.018_bib7","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2022.02.018_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.02.018_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2022.02.018_bib10","doi-asserted-by":"crossref","DOI":"10.21037\/acs.2017.03.14","article-title":"8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice","author":"Rice","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.ejca.2022.02.018_bib11","article-title":"Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC\/UICC staging manuals","author":"Rice","year":"2016","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ejca.2022.02.018_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2022.02.018_bib13","first-page":"1","article-title":"Oligometastatic prostate cancer: results of a Dutch multidisciplinary consensus meeting","author":"Aluwini","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejca.2022.02.018_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.ejca.2022.02.018_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2020.09.042","article-title":"Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer","volume":"154","author":"Li","year":"2021","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/mco.2020.2065","article-title":"Linear accelerator-based stereotactic body radiation therapy in the treatment of oligometastatic disease","volume":"13","author":"Yamashita","year":"2020","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ejca.2022.02.018_bib18","article-title":"Efficacy of radiotherapy inoligometastatic esophageal squamous cell cancer patients: new evidence from A retrospective study","author":"Li","year":"2020","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2022.02.018_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1245\/s10434-019-08175-0","article-title":"Clinicopathologic characteristics of oligometastases from esophageal cancer and long-term outcomes of resection","volume":"27","author":"Ohkura","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2022.02.018_bib20","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/j.ijrobp.2020.07.1886","article-title":"Survival and patterns of failure in oligometastatic esophagogastric cancer","volume":"108","author":"Hilal","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.02.018_bib21","article-title":"Oligometastatic recurrence as a prognostic factor after curative resection of esophageal squamous cell carcinoma","author":"Morinaga","year":"2020","journal-title":"Surg Today"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib22","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.21037\/jtd.2019.03.10","article-title":"Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases","volume":"11","author":"Chen","year":"2019","journal-title":"J Thorac Dis"},{"issue":"5","key":"10.1016\/j.ejca.2022.02.018_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5152\/dir.2019.18390","article-title":"Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy","volume":"25","author":"Omari","year":"2019","journal-title":"Diagnostic Interv Radiol"},{"issue":"15_suppl","key":"10.1016\/j.ejca.2022.02.018_bib24","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.e15523","article-title":"The prognostic factors associated with long-term survival in the patients with synchronous oligometastatic esophageal adenocarcinoma","volume":"37","author":"Iwatsuki","year":"2019","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2022.02.018_bib25","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ejso.2018.03.019","article-title":"Surgery for metastases for esophageal-gastric cancer in the real world: data from the AGAMENON national registry","volume":"44","author":"Carmona-Bayonas","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.athoracsur.2017.10.039","article-title":"Predictors of survival aftertreatment of oligometastases after esophagectomy","volume":"105","author":"Ghaly","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.ejca.2022.02.018_bib27","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s00268-017-4430-8","article-title":"Treatment outcomes and prognostic factors after recurrence of esophageal squamous cell carcinoma","volume":"42","author":"Hamai","year":"2018","journal-title":"World J Surg"},{"issue":"7","key":"10.1016\/j.ejca.2022.02.018_bib28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/0218492318797228","article-title":"Palliative esophagectomy in unexpected metastatic disease: sense or nonsense?","volume":"26","author":"Depypere","year":"2018","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib29","first-page":"1","article-title":"Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road","volume":"30","author":"Depypere","year":"2017","journal-title":"Dis Esophagus"},{"issue":"10","key":"10.1016\/j.ejca.2022.02.018_bib30","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ejso.2015.05.005","article-title":"Surgery in oesophago-gastric cancer with metastatic disease: treatment, prognosis and preoperative patient selection","volume":"41","author":"Schmidt","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2022.02.018_bib31","doi-asserted-by":"crossref","first-page":"C267","DOI":"10.4103\/0973-1482.151487","article-title":"Concurrent involved-field radiotherapy and XELOX in gastric cancer patients with postoperative oligometastatic recurrence","volume":"10","author":"Xu","year":"2014","journal-title":"J Cancer Res Therapeut"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00268-012-1830-7","article-title":"Pattern of postoperative recurrence and hepatic and\/or pulmonary resection for liver and\/or lung metastases from esophageal carcinoma","volume":"37","author":"Ichida","year":"2013","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.athoracsur.2012.03.075","article-title":"Definitive therapy for isolated esophageal metastases prolongs survival","volume":"94","author":"Port","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10120-011-0015-7","article-title":"Survival benefit of gastrectomy \u00b1 metastasectomy in patients with metastatic gastric cancer receiving chemotherapy","volume":"14","author":"Kim","year":"2011","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejca.2022.02.018_bib35","series-title":"Testing the addition of radiotherapy to the usual treatment (chemotherapy) for patients with esophageal and gastric cancer that has spread to a limited number of other places in the body","year":"2020"},{"key":"10.1016\/j.ejca.2022.02.018_bib36","author":"Nguyen"},{"key":"10.1016\/j.ejca.2022.02.018_bib37","series-title":"Local therapy for oligorecurrent and oligometastatic esophageal squamous cell carcinoma","first-page":"1","author":"Zhao","year":"2021"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12885-017-3918-9","article-title":"The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III tri","volume":"17","author":"Al-Batran","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2022.02.018_bib39","series-title":"Chemotherapy alone versus surgery pluschemotherapy for distal gastric cancer with one non-curable factor. Clinicaltrials.gov\/NCT03399253","first-page":"1","author":"Xu","year":"2020"},{"key":"10.1016\/j.ejca.2022.02.018_bib40","article-title":"Conversion therapy with sintilimab plus CAPOX in patients with unresectable locally advanced or limited metastatic adenocarcinoma of the stomach or esophagogastric junction","author":"Ding","year":"2020","journal-title":"Case Med Res"},{"key":"10.1016\/j.ejca.2022.02.018_bib41","series-title":"PD-1 antibody combined with modified FLOT regimen in the treatment ofUnresectable locally advanced or limited metastatic gastric cancer. clinicaltrials.gov\/NCT04510064","author":"Guo","year":"2021"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3156-1","article-title":"Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10120-017-0730-9","article-title":"Role of hepatectomy in gastric cancer with multiple liver-limited metastases","volume":"21","author":"Shirasu","year":"2018","journal-title":"Gastric Cancer"},{"issue":"41","key":"10.1016\/j.ejca.2022.02.018_bib44","doi-asserted-by":"crossref","first-page":"71147","DOI":"10.18632\/oncotarget.16705","article-title":"Surgical resection for hepatic metastasis from gastric cancer: a multi- institution study","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ejca.2022.02.018_bib45","first-page":"2367","article-title":"Indication for hepatic resection in the treatment of liver metastasis from gastric cancer","volume":"30","author":"Makino","year":"2010","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.ejca.2022.02.018_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520940509","article-title":"Radiofrequency ablation versus traditional liver resection and chemotherapy for liver metastases from gastric cancer","volume":"48","author":"Tang","year":"2020","journal-title":"J Int Med Res"},{"issue":"7","key":"10.1016\/j.ejca.2022.02.018_bib47","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ejso.2013.03.006","article-title":"Hepatic resection for synchronous hepatic metastasis from gastric cancer","volume":"39","author":"Qiu","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2022.02.018_bib48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4292\/wjgpt.v11.i5.110","article-title":"Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience","volume":"11","author":"Yazawa","year":"2020","journal-title":"World J Gastrointest Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s13304-018-0536-2","article-title":"Surgical treatment of hepatic metastases from gastric cancer","volume":"70","author":"Ministrini","year":"2018","journal-title":"Updates Surg"},{"issue":"6","key":"10.1016\/j.ejca.2022.02.018_bib50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s11605-015-2775-6","article-title":"Survival benefit of surgical treatment for liver metastases from gastric cancer","volume":"19","author":"Shinohara","year":"2015","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.ejca.2022.02.018_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0258-3","article-title":"Prognostic significance of radical surgical treatment for gastric cancer patients with synchronous liver metastases","volume":"31","author":"Wang","year":"2014","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2482-12-20","article-title":"Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Surg"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2478\/raon-2020-0067","article-title":"Surgical resection of synchronous liver metastases in gastric cancer patients. A propensity score-matched study","volume":"55","author":"Jagric","year":"2020","journal-title":"Radiol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2022.02.018_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1477-2574.2011.00428.x","article-title":"Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?","volume":"14","author":"Garancini","year":"2012","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.asjsur.2017.09.005","article-title":"Oncological outcomes after hepatic resection and\/or surgical microwave ablation for liver metastasis from gastric cancer","volume":"42","author":"Ryu","year":"2019","journal-title":"Asian J Surg"},{"issue":"January","key":"10.1016\/j.ejca.2022.02.018_bib56","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/S0959-8049(17)30320-9","article-title":"Approaches for optimal choice in treatment of gastric cancer with liver metastases","volume":"72","author":"Djuraev","year":"2017","journal-title":"Eur J Cancer"},{"issue":"13","key":"10.1016\/j.ejca.2022.02.018_bib57","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3748\/wjg.v19.i13.2097","article-title":"Chemotherapy and resection for gastric cancer with synchronous liver metastases","volume":"19","author":"Chen","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ejca.2022.02.018_bib58","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10120-015-0522-z","article-title":"Liver-directed treatments for liver\u00a0metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation","volume":"19","author":"Guner","year":"2016","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2022.02.018_bib59","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jhbp.343","article-title":"Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer","volume":"23","author":"Oguro","year":"2016","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"11","key":"10.1016\/j.ejca.2022.02.018_bib60","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s12094-015-1321-z","article-title":"Systemic chemotherapy as a main strategy for liver metastases from gastric cancer","volume":"17","author":"Zhang","year":"2015","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib61","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1111\/ans.13810","article-title":"Hepatic resection for post-operative solitary liver metastasis from oesophageal squamous cell carcinoma","volume":"88","author":"Liu","year":"2018","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s13193-018-0827-6","article-title":"Evaluation of hepatic resection in liver metastasis of gastric cancer","volume":"10","author":"Nonaka","year":"2019","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.35772\/ghm.2019.01012","article-title":"Intestinal-type histology is associated with better prognosis in patients undergoing liver resection for gastric\/esophagogastric-junction liver metastasis","volume":"1","author":"Ito","year":"2019","journal-title":"Glob Heal Med"},{"issue":"3","key":"10.1016\/j.ejca.2022.02.018_bib64","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10120-015-0530-z","article-title":"Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)","volume":"19","author":"Oki","year":"2016","journal-title":"Gastric Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2022.02.018_bib65","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.3748\/wjg.v21.i9.2754","article-title":"Radical gastrectomy with hepatoarterial catheter implantation for late-stage gastric cancer","volume":"21","author":"Yao","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib66","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5230\/jgc.2013.13.2.86","article-title":"Hepatic resection for hepatic metastases from gastric adenocarcinoma","volume":"13","author":"Baek","year":"2013","journal-title":"J Gastric Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib67","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.7314\/APJCP.2015.16.4.1665","article-title":"Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China","volume":"16","author":"Liu","year":"2015","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"5","key":"10.1016\/j.ejca.2022.02.018_bib68","first-page":"747","article-title":"Correlation between the survival rate of the patients with synchronous hepatic metastases from gastric carcinoma after surgical resection and patient's index","volume":"125","author":"Yang","year":"2012","journal-title":"Chin Med J"},{"issue":"37","key":"10.1016\/j.ejca.2022.02.018_bib69","doi-asserted-by":"crossref","first-page":"61861","DOI":"10.18632\/oncotarget.18709","article-title":"Evaluation of hepatectomy and palliative local treatments for gastric cancer patients with liver metastases: a propensity score matching analysis","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib70","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12072-009-9161-y","article-title":"Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer","volume":"4","author":"Tsujimoto","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ejca.2022.02.018_bib71","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.2147\/CMAR.S261353","article-title":"Treatment of synchronous liver metastases from gastric cancer: a single-center study","volume":"12","author":"Yu","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"11","key":"10.1016\/j.ejca.2022.02.018_bib72","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s00268-015-3151-0","article-title":"Hepatectomy offers superior survival compared with non-surgical treatment for \u22643 metastatic tumors with diameters < 3 cm from gastric cancer: aretrospective study","volume":"39","author":"Ohkura","year":"2015","journal-title":"World J Surg"},{"key":"10.1016\/j.ejca.2022.02.018_bib73","first-page":"v40","article-title":"Efficacy and indication of liver resection for liver metastases from gastric cancer","volume":"22","author":"Saiura","year":"2011","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2022.02.018_bib74","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1007\/s00268-014-2608-x","article-title":"High survival in patients operated for small isolated liver metastases from gastric cancer: amulti-institutional study","volume":"38","author":"Komeda","year":"2015","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib75","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10120-016-0611-7","article-title":"Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging","volume":"20","author":"Tatsubayashi","year":"2017","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10120-011-0080-y","article-title":"Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature","volume":"15","author":"Dittmar","year":"2012","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2022.02.018_bib77","first-page":"1","article-title":"Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study","volume":"32","author":"Seesing","year":"2020","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib78","doi-asserted-by":"crossref","first-page":"E224","DOI":"10.1016\/j.ijrobp.2019.06.1982","article-title":"Image-guided proton therapy (IGPT) for oligometastatic liver tumors from gastric\/colorectal cancer","volume":"105","author":"Nakajima","year":"2019","journal-title":"Int J Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib79","article-title":"Radiofrequency ablation for pulmonary metastases from esophageal squamous cell carcinoma","volume":"34","author":"Shigaki","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib80","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10388-015-0506-4","article-title":"Pulmonary metastasectomy for metachronous metastasis of esophageal cancer after esophagectomy","volume":"13","author":"M","year":"2016","journal-title":"Esophagus"},{"issue":"10","key":"10.1016\/j.ejca.2022.02.018_bib81","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s11748-020-01373-8","article-title":"Survival outcomes of resection for pulmonary malignancies including non-small cell\u00a0lung cancer and pulmonary metastasis after esophagectomy for esophageal carcinoma","volume":"68","author":"Yamanashi","year":"2020","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib82","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.21873\/anticanres.14164","article-title":"Stereotactic body radiotherapy for pulmonary oligometastases from esophageal cancer: results and prognostic factors","volume":"40","author":"Yamamoto","year":"2020","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.ejca.2022.02.018_bib83","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.surg.2010.07.047","article-title":"Operative treatment for metachronous pulmonary metastasis from esophageal carcinoma","volume":"149","author":"Ichikawa","year":"2011","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib84","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5761\/atcs.oa.16-00049","article-title":"Pulmonary resection for metastatic gastric cancer","volume":"22","author":"Iijima","year":"2016","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.ejca.2022.02.018_bib85","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/jjco\/hyy146","article-title":"Clinical prediction of solitary pulmonary nodule after a curative resection for gastric cancer","volume":"48","author":"Kanai","year":"2018","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jjco\/hyw141","article-title":"The role of pulmonary resection in tumors metastatic from esophageal carcinoma","volume":"47","author":"Kanamori","year":"2017","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2022.02.018_bib87","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00595-012-0432-1","article-title":"Pulmonary metastasectomy for gastric cancer: a 13-year single-institution experience","volume":"43","author":"Kobayashi","year":"2013","journal-title":"Surg Today"},{"issue":"10","key":"10.1016\/j.ejca.2022.02.018_bib88","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jvir.2014.06.030","article-title":"Percutaneous radiofrequency ablation for pulmonary metastases from esophageal cancer: retrospective evaluation of 21 patients","volume":"25","author":"Matsui","year":"2014","journal-title":"J Vasc Intervent Radiol"},{"issue":"3","key":"10.1016\/j.ejca.2022.02.018_bib89","first-page":"418","article-title":"Surgery for malignant pulmonary nodules in patients with a history of oesophageal cancer","volume":"24","author":"Kanzaki","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"9","key":"10.1016\/j.ejca.2022.02.018_bib90","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00595-014-1036-8","article-title":"Surgical outcomes of pulmonary metastases from esophageal carcinoma diagnosed by both pathological and clinical criteria","volume":"45","author":"Kozu","year":"2015","journal-title":"Surg Today"},{"issue":"5","key":"10.1016\/j.ejca.2022.02.018_bib91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5761\/atcs.oa.19-00075","article-title":"Impact of perioperative chemotherapy on prognosis of patients with esophageal carcinoma undergoing pulmonary metastasectomy","volume":"25","author":"Komatsu","year":"2019","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"SUPPL. 3","key":"10.1016\/j.ejca.2022.02.018_bib92","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1245\/s10434-014-3677-7","article-title":"Pulmonary metastasectomy secondary to esophageal carcinoma: long-term survival and prognostic factors","volume":"21","author":"Kobayashi","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2022.02.018_bib93","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jvir.2016.05.017","article-title":"Long-term survival after radiofrequency ablation of lung oligometastases from five types of primary lesions: aretrospective evaluation","volume":"27","author":"Omae","year":"2016","journal-title":"J Vasc Intervent Radiol"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib94","first-page":"401","article-title":"The impact of pulmonary metastasectomy from gastric cancer","volume":"11","author":"Oguri","year":"2019","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8090-7-103","article-title":"Metachronous pulmonary metastasis after radical esophagectomy for esophageal cancer: prognosis and outcome","volume":"7","author":"Takemura","year":"2012","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ejcts\/ezs574","article-title":"Outcomes and prognostic factors of survival after pulmonary resection for metastatic gastric cancer","volume":"43","author":"Shiono","year":"2013","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"5","key":"10.1016\/j.ejca.2022.02.018_bib97","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/0218492313513777","article-title":"Ten cases of resected solitary pulmonary metastases arising from gastric cancer","volume":"22","author":"Yoshida","year":"2014","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"5","key":"10.1016\/j.ejca.2022.02.018_bib98","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.21037\/jtd.2018.05.17","article-title":"Long-term outcome after resection for recurrent oesophageal cancer","volume":"10","author":"Kato","year":"2018","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.ejca.2022.02.018_bib99","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1442-2050.2010.01119.x","article-title":"Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy","volume":"24","author":"Maruyama","year":"2011","journal-title":"Dis Esophagus"},{"issue":"Supplement 4","key":"10.1016\/j.ejca.2022.02.018_bib100","doi-asserted-by":"crossref","first-page":"iv14","DOI":"10.1093\/annonc\/mdv233.50","article-title":"P-050 the role of radiotherapy or chemoradiotherapy for oligo-recurrence of esophageal cancer after curative resection or chemoradiotherapy","volume":"26","author":"Matsumoto","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00280-010-1296-y","article-title":"Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement","volume":"67","author":"Park","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.ejca.2022.02.018_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13050983","article-title":"Neoadjuvant chemoradiotherapy followed by esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma patients with clinical stage iii and with supraclavicular lymph node metastasis","volume":"13","author":"Sato","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib103","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.wneu.2013.02.058","article-title":"Brain metastases from esophageal cancer: clinical review of 26 cases","volume":"81","author":"Song","year":"2014","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11060-014-1408-3","article-title":"Gamma knife radiosurgery for management of cerebral metastases from esophageal carcinoma","volume":"118","author":"Bowden","year":"2014","journal-title":"J Neuro Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2022.02.018_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox071","article-title":"Incidence of brain metastasis from esophageal cancer","volume":"30","author":"Welch","year":"2017","journal-title":"Dis Esophagus"},{"issue":"4","key":"10.1016\/j.ejca.2022.02.018_bib106","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00701-009-0554-4","article-title":"Radiosurgery for brain metastasis from advanced gastric cancer","volume":"152","author":"Han","year":"2010","journal-title":"Acta Neurochir"},{"issue":"3","key":"10.1016\/j.ejca.2022.02.018_bib107","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11060-010-0405-4","article-title":"The efficacy of gamma knife radiosurgery for advanced gastric cancer with brain metastases","volume":"103","author":"Park","year":"2011","journal-title":"J Neuro Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2022.02.018_bib108","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7150\/jca.21511","article-title":"Characteristics and treatment of brain metastases from esophageal squamous cell carcinoma","volume":"9","author":"Li","year":"2018","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib109","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/mco.2017.1263","article-title":"Outcomes of aggressive treatment in esophageal cancer patients with synchronous solitary brain metastasis","volume":"7","author":"Onal","year":"2017","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.02.018_bib110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13304-010-0012-0","article-title":"Adrenal metastases from adenocarcinoma of the esophagogastric junction: adrenalectomy and long-term survival","volume":"62","author":"Fumagalli","year":"2010","journal-title":"Updates Surg"},{"key":"10.1016\/j.ejca.2022.02.018_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2018.07.132","article-title":"Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: a systematic review and meta-analysis","author":"ter Veer","year":"2018","journal-title":"Eur J Cancer"},{"issue":"9742","key":"10.1016\/j.ejca.2022.02.018_bib112","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"10142","key":"10.1016\/j.ejca.2022.02.018_bib113","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(18)31257-1","article-title":"Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial","volume":"392","author":"Shitara","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2022.02.018_bib114","first-page":"18","volume":"vol. 164","author":"Kroese","year":"2022"},{"issue":"12","key":"10.1016\/j.ejca.2022.02.018_bib115","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","article-title":"Definition of synchronous oligometastatic non\u2013small cell lung cancer\u2014aconsensus report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2022.02.018_bib116","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. Maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.02.018_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","author":"Fujitani","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.02.018_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2009.03.003","article-title":"Impact of integrated PET\/CT in the staging of oesophageal cancer-a UK population-based cohort study","author":"Noble","year":"2009","journal-title":"Clin Radiol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922001101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922001101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:37:14Z","timestamp":1760733434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":118,"alternative-id":["S0959804922001101"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.02.018","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A\u00a0systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}